Editas Medicine EDIT
NASDAQ EDIT
$2.49 -0.02 (-0.80%)
At close: Oct 22, 2026 · 4:00 PM EDT

Editas Medicine (EDIT) Long-Term Debt Repayments (2015 - 2025)

Updated

Editas Medicine (EDIT) posted Long-Term Debt Repayments of $2.87 million for Q1 2025.

Analysis

Editas Medicine (EDIT) Long-Term Debt Repayments (2015 - 2025) Analysis & Trends

For FY2017, Editas Medicine's Long-Term Debt Repayments came in at $600,000.

  • In prior years, Editas Medicine's Long-Term Debt Repayments was $2 million in FY2015.
  • The Q1 2025 figure stands as the lowest quarterly Long-Term Debt Repayments since Q4 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 1.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 2.00 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 2.46 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 17.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Editas Medicine 222.97 Mn -488.78 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 2.87 Mn
Dec 31, 2018 236,000.00
Sep 30, 2018 211,000.00
Jun 30, 2018 207,000.00
Mar 31, 2018 203,000.00
Dec 31, 2017 199,000.00
Sep 30, 2017 775,000.00
Jun 30, 2017 -53,000.00
Mar 31, 2017 443,000.00
Dec 31, 2015 1.93 Mn
Sep 30, 2015 42,000.00
API Access

Editas Medicine Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=EDIT&period=max&api_key=YOUR_API_KEY